Stock Price & Analysis

Based on the recent market data and analysis, here's a concise assessment of UNH stock:

Technical Analysis The stock is currently trading at $509.76, showing a slight decline of -0.16% in regular market hours . The stock has formed a consolidation pattern near the Fibonacci support level of $507.52, with resistance at $541.60.

Fundamental Strength UnitedHealth remains fundamentally strong with analysts maintaining positive ratings. Bernstein recently reaffirmed their Outperform rating with a $697 price target, suggesting a 37% upside potential. The company's 2025 outlook is considered achievable, with improving Medicare Advantage trends.

Recent Performance & Valuation The stock is currently trading at a forward P/E of 17.57x, below its 5-year average of 23.29x, indicating potential value at current levels. The RSI of 41.72 suggests the stock is neither overbought nor oversold.

Analyst Consensus Multiple analysts maintain bullish ratings on UNH:

• Cantor Fitzgerald: Buy rating, $700 price target
• Keybanc: Buy rating, $650 price target
• Barclays: Buy rating, $642 price target

Recommendation SELL. Despite strong fundamentals and positive analyst outlook, technical indicators suggest potential near-term weakness. The stock is testing support levels, and with the current market uncertainty and healthcare sector headwinds, it would be prudent to wait for a more attractive entry point below $500.

Based on the provided data and recent analyst reports, here's the price prediction for UNH stock in 2025:

UnitedHealth Group (UNH) is expected to reach $650-697 by the end of 2025, representing a potential upside of 27-37% from the current price of $510.5. This projection is supported by several key factors:

Key Growth Drivers:

• Strong earnings momentum with projected EPS of $29.50-$30.00 for 2025
• Improving Medicare Advantage trends and attractive valuation metrics
• Solid business fundamentals through both UnitedHealthcare and Optum segments

Analyst Consensus:

• Bernstein maintains an Outperform rating with a $697 price target
• Strong Buy consensus from 22 out of 24 analysts covering the stock
• Average analyst price target of $641.08

Technical Analysis: The stock is showing positive momentum after finding support at the $553-558 level, with the 200-day moving average trending upward. The RSI indicates bullish sentiment without reaching overbought conditions, suggesting room for further upside.

The S1 support level for UNH Stock is $508.91 ,The R1 resistant level for UNH Stock is $542.98.

As of the end of day on 2025-01-24, the price of UNH Stock was $531.56.

The target price for UNH Stock according to analyst rating is 642.17, with the highest price target at 715.00 and the lowest at 595.00. Analysts have a Strong Buy rating on UNH Stock overall.

The market cap of UNH is $490.1B.

Based on the provided data and recent analyst coverage, here's a comprehensive analysis of UNH's valuation:

Valuation Analysis: UNH currently shows mixed valuation signals. The stock trades at a P/E ratio of 32.62x (Q4 2024), which is relatively high compared to its historical average and indicates potential overvaluation from an earnings perspective.

Recent Price Movement:

Key Valuation Metrics Support Overvaluation:

• EV/EBITDA of 11x in Q4 2024 shows improvement but remains elevated
• Price-to-Sales ratio of 1.17x suggests reasonable valuation on revenue basis
• Price-to-Book ratio of 4.74x indicates premium to book value
• ROE trending down from 18.29% to 15.40% over past quarters

Analyst Consensus: Recent analyst actions support this view, with Barclays lowering price target to $642 from $655 on January 17, 2025, citing medical loss ratio headwinds. Multiple analysts have adjusted their targets downward, reflecting concerns about valuation and sector pressures.

Conclusion: UNH appears overvalued at current levels due to compressed margins, declining ROE, and elevated earnings multiples, while facing headwinds from rising medical costs and regulatory pressures.

UnitedHealth Group Incorporated is a healthcare company. The Company has two businesses, Optum and UnitedHealthcare. Optum serves the health care marketplace, including patients and consumers, payers, care providers, employers, governments and life sciences companies. UnitedHealthcare offers a full range of health benefits designed to simplify the health care experience and make it more affordable for consumers to access care. UnitedHealthcare Employer & Individual serves consumers and employers, ranging from sole proprietorships to large, multi-site and national employers and public sector employers. UnitedHealthcare Medicare & Retirement delivers health and well-being benefits to seniors and other Medicare eligible consumers. The Company’s segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. UnitedHealthcare segment includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State.

Based on analyst projections and market trends, UnitedHealth (UNH) stock is expected to reach approximately $697 by 2030, driven by continued strong earnings growth and improving Medicare Advantage trends. The company's solid leadership position in managed healthcare and strategic acquisitions support this bullish outlook. Technical indicators and long-term growth trajectory suggest UNH could potentially exceed $700 by 2030, supported by its consistent 13-16% annual adjusted EPS growth target.

UNH has a total of 440000 employees.